Moderna
MRNA
#1116
Rank
HK$157.89 B
Marketcap
HK$398.15
Share price
5.33%
Change (1 day)
80.48%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Net assets

Net assets on the balance sheet as of December 2025 : HK$67.79 Billion

According to Moderna 's latest financial reports the company has HK$67.79 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Moderna - Net assets on balance sheet (from 2017 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$HK$67.30 B-20.47%
2024-12-31$HK$84.62 B-21.78%
2023-12-31$HK$108.20 B-27.58%
2022-12-31$HK$149.41 B35.46%
2021-12-31$HK$110.29 B455.56%
2020-12-31$HK$19.85 B116.99%
2019-12-31$HK$9.14 B-23.65%
2018-12-31$HK$11.98 B145.28%
2017-12-31$HK$4.88 B-25.16%
2016-12-31$HK$6.52 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
HK$639.10 B 842.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$364.82 B 438.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$412.73 B 508.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
HK$0.54 B-99.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-HK$0.29 Billion-100.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$6.18 B-90.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$4.41 B-93.49%๐Ÿ‡บ๐Ÿ‡ธ USA